• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MLA
Click for more information
0.00% 8.5¢

MEDICAL AUSTRALIA LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
MLA Removal from Official List (COB 30/11/2017)30/11/17
MLA IMPLEMENTATION OF SCHEME OF ARRANGEMENT30/11/17
MLA LODGMENT OF COURT ORDERS WITH ASIC20/11/17
MLA Suspension from Official Quotation (COB 20/11/2017)PRICE SENSITIVE20/11/17
MLA COURT APPROVES SCHEME OF ARRANGEMENTPRICE SENSITIVE17/11/17
MLA Substituted annexure to announcement re Scheme Meeting15/11/17
MLA AMENDED ANNEXURE TO ANNOUNCEMENT RE SCHEME MEETING15/11/17
MLA MLA SHAREHOLDERS APPROVE SCHEMEPRICE SENSITIVE15/11/17
MLA Appendix 4C - quarterlyPRICE SENSITIVE19/10/17
MLA 2017 Annual General Meeting - Advice of ASIC Relief13/10/17
MLA DISPATCH OF SCHEME BOOKLET TO SHAREHOLDERSPRICE SENSITIVE13/10/17
MLA Scheme Booklet Registered with ASIC06/10/17
MLA Court approves Scheme Booklet and Convening of MeetingPRICE SENSITIVE04/10/17
MLA APPENDIX 4G27/09/17
MLA Annual Report to shareholders27/09/17
MLA Scheme Of Arrangement Update14/09/17
MLA APPENDIX 4E AND PRELIMINARY FINAL REPORTPRICE SENSITIVE30/08/17
MLA MLA & ICU MEDICAL INC SIGNS SCHEME IMPLEMENTATION AGREEMENTPRICE SENSITIVE10/08/17
MLA MLA records revenue of $3.29 million for Q4 FY2017PRICE SENSITIVE31/07/17
MLA MLA Quarterly Update March 201726/04/17
MLA Appendix 4C March 2017 QuarterPRICE SENSITIVE26/04/17
MLA Half Yearly Report and AccountsPRICE SENSITIVE28/02/17
MLA Ardo Breast Pump AgreementPRICE SENSITIVE22/02/17
MLA Change in substantial holding15/02/17
MLA Product Update10/02/17
MLA Change in substantial holding07/02/17
MLA Quarterly ReportPRICE SENSITIVE31/01/17
MLA Appendix 4C - quarterlyPRICE SENSITIVE31/01/17
MLA Change in substantial holding27/01/17
MLA Results of Meeting28/11/16
MLA Quarterly Report-MLA.AX PRICE SENSITIVE31/10/16
MLA Appendix 4C - quarterly-MLA.AX PRICE SENSITIVE31/10/16
MLA Notice of Annual General Meeting-MLA.AX 21/10/16
MLA Appendix 4G-MLA.AX 30/09/16
MLA Annual Report to shareholders-MLA.AX 30/09/16
MLA Progress Report-MLA.AX PRICE SENSITIVE05/09/16
MLA Preliminary Final Report-MLA.AX PRICE SENSITIVE31/08/16
MLA Details of Share Registry address-MLA.AX 29/08/16
MLA Change in substantial holding-MLA.AX 18/08/16
MLA Appendix 4C - quarterly-MLA.AX PRICE SENSITIVE29/07/16
MLA Quarterly Cashflow Report-MLA.AX PRICE SENSITIVE29/07/16
MLA MLA completes final phase of MediVet divestment-MLA.AX 17/06/16
MLA Distribution Agreement with Ardo-MLA.AX PRICE SENSITIVE17/05/16
MLA Change in substantial holding-MLA.AX 05/05/16
MLA Change in substantial holding-MLA.AX 04/05/16
MLA Appendix 4C and Commentary-MLA.AX PRICE SENSITIVE13/04/16
MLA Medical Australia Limited Interim Financial ReportPRICE SENSITIVE29/02/16
MLA Response to ASX Appendix 4C QueryPRICE SENSITIVE10/02/16
MLA Exclusive Distribution Rights for DuelCap System SecuredPRICE SENSITIVE08/02/16
MLA Quarterly Report - December 201529/01/16
MLA Appendix 4C - 31 December 2015PRICE SENSITIVE29/01/16
MLA MLA Finalises Sale of MediVetPRICE SENSITIVE22/12/15
MLA Release of Restricted Securities from Voluntary Escrow23/11/15
MLA Medivet Biologics US Animal Health BusinessPRICE SENSITIVE13/11/15
MLA Results of Annual General Meeting13/11/15
MLA Quarterly Report - September 201530/10/15
MLA Appendix 4C - 30 September 2015PRICE SENSITIVE30/10/15
MLA Notice of AGM & Explanatory Memorandum13/10/15
MLA Appendix 4G30/09/15
MLA 2015 Annual Report30/09/15
MLA Revenue Report for Year Ended 30 June 201531/08/15
MLA Appendix 4E - 30 June 2015PRICE SENSITIVE31/08/15
MLA Appendix 3Z - Jeremy Delk21/08/15
MLA Resignation of Jeremy Delk as a Director21/08/15
MLA Updated Contact Details for Share Registry20/08/15
MLA Response to Appendix 4C QueryPRICE SENSITIVE07/08/15
MLA Quarterly Report - 30 June 201531/07/15
MLA Appendix 4C - 30 June 2015PRICE SENSITIVE31/07/15
MLA Change of Share Registry Name10/07/15
MLA Focus on Human Healthcare & Dilution of Animal BusinessPRICE SENSITIVE23/06/15
MLA Appendix 4C - 31 March 2015PRICE SENSITIVE30/04/15
MLA Quarterly Report - 31 March 2015PRICE SENSITIVE30/04/15
MLA Notice of Change of Interests of Substantial Holder20/03/15
MLA Form 603 - Notice of Initial Substantial Holder20/03/15
MLA Terms of Incentive Share Scheme - CEO10/03/15
MLA Half Yearly Commentary27/02/15
MLA Quarterly Report for Period Ended 31 December 2014PRICE SENSITIVE27/02/15
MLA Quarterly Report & Appendix 4C - 31 December 2014PRICE SENSITIVE30/01/15
MLA Updated Contact Details for Share Registry21/01/15
MLA MLA Subsidiary to help Develop Canine Cancer TreatmentPRICE SENSITIVE19/01/15
MLA Terms of Appointment of CEO04/12/14
MLA Release of Restricted Securities from Voluntary Escrow04/12/14
MLA Darryl Ellis appointed as CEO of Medical Australia LimitedPRICE SENSITIVE02/12/14
MLA Release of Restricted Securities from Voluntary Escrow21/11/14
MLA Notice of Initial Substantial Holder - Pie Funds Management14/11/14
MLA Becoming a substantial holder14/11/14
MLA Change in substantial holding13/11/14
MLA Change in substantial holding notices13/11/14
MLA Notice in Accordance with the Corporations Act 200112/11/14
MLA Amended Number of Shares Issued Pursuant to Rights Issue12/11/14
MLA Further Amended Notification of Under-Subscriptions12/11/14
MLA Shares Listed Pursuant to Non-Renounceable Rights Issue10/11/14
MLA Amended Notification of Under-Subscriptions - Rights Issue10/11/14
MLA Appendix 3Y - Ian Mitchell07/11/14
MLA Notification of Under-Subscriptions - Rights Issue07/11/14
MLA Results of Annual General Meeting06/11/14
MLA Appendix 4C - 30.9.14PRICE SENSITIVE28/10/14
MLA Quarterly Report - September 2014PRICE SENSITIVE28/10/14
MLA Non-Renounceable Rights Issue Offer DocumentPRICE SENSITIVE14/10/14
MLA Appendix 3B14/10/14
MLA Removal from Official List (COB 30/11/2017)
30/11/17
MLA IMPLEMENTATION OF SCHEME OF ARRANGEMENT
30/11/17
MLA LODGMENT OF COURT ORDERS WITH ASIC
20/11/17
MLA Suspension from Official Quotation (COB 20/11/2017)
20/11/17PRICE SENSITIVE
MLA COURT APPROVES SCHEME OF ARRANGEMENT
17/11/17PRICE SENSITIVE
MLA Substituted annexure to announcement re Scheme Meeting
15/11/17
MLA AMENDED ANNEXURE TO ANNOUNCEMENT RE SCHEME MEETING
15/11/17
MLA MLA SHAREHOLDERS APPROVE SCHEME
15/11/17PRICE SENSITIVE
MLA Appendix 4C - quarterly
19/10/17PRICE SENSITIVE
MLA 2017 Annual General Meeting - Advice of ASIC Relief
13/10/17
MLA DISPATCH OF SCHEME BOOKLET TO SHAREHOLDERS
13/10/17PRICE SENSITIVE
MLA Scheme Booklet Registered with ASIC
06/10/17
MLA Court approves Scheme Booklet and Convening of Meeting
04/10/17PRICE SENSITIVE
MLA APPENDIX 4G
27/09/17
MLA Annual Report to shareholders
27/09/17
MLA Scheme Of Arrangement Update
14/09/17
MLA APPENDIX 4E AND PRELIMINARY FINAL REPORT
30/08/17PRICE SENSITIVE
MLA MLA & ICU MEDICAL INC SIGNS SCHEME IMPLEMENTATION AGREEMENT
10/08/17PRICE SENSITIVE
MLA MLA records revenue of $3.29 million for Q4 FY2017
31/07/17PRICE SENSITIVE
MLA MLA Quarterly Update March 2017
26/04/17
MLA Appendix 4C March 2017 Quarter
26/04/17PRICE SENSITIVE
MLA Half Yearly Report and Accounts
28/02/17PRICE SENSITIVE
MLA Ardo Breast Pump Agreement
22/02/17PRICE SENSITIVE
MLA Change in substantial holding
15/02/17
MLA Product Update
10/02/17
MLA Change in substantial holding
07/02/17
MLA Quarterly Report
31/01/17PRICE SENSITIVE
MLA Appendix 4C - quarterly
31/01/17PRICE SENSITIVE
MLA Change in substantial holding
27/01/17
MLA Results of Meeting
28/11/16
MLA Quarterly Report-MLA.AX
31/10/16PRICE SENSITIVE
MLA Appendix 4C - quarterly-MLA.AX
31/10/16PRICE SENSITIVE
MLA Notice of Annual General Meeting-MLA.AX
21/10/16
MLA Appendix 4G-MLA.AX
30/09/16
MLA Annual Report to shareholders-MLA.AX
30/09/16
MLA Progress Report-MLA.AX
05/09/16PRICE SENSITIVE
MLA Preliminary Final Report-MLA.AX
31/08/16PRICE SENSITIVE
MLA Details of Share Registry address-MLA.AX
29/08/16
MLA Change in substantial holding-MLA.AX
18/08/16
MLA Appendix 4C - quarterly-MLA.AX
29/07/16PRICE SENSITIVE
MLA Quarterly Cashflow Report-MLA.AX
29/07/16PRICE SENSITIVE
MLA MLA completes final phase of MediVet divestment-MLA.AX
17/06/16
MLA Distribution Agreement with Ardo-MLA.AX
17/05/16PRICE SENSITIVE
MLA Change in substantial holding-MLA.AX
05/05/16
MLA Change in substantial holding-MLA.AX
04/05/16
MLA Appendix 4C and Commentary-MLA.AX
13/04/16PRICE SENSITIVE
MLA Medical Australia Limited Interim Financial Report
29/02/16PRICE SENSITIVE
MLA Response to ASX Appendix 4C Query
10/02/16PRICE SENSITIVE
MLA Exclusive Distribution Rights for DuelCap System Secured
08/02/16PRICE SENSITIVE
MLA Quarterly Report - December 2015
29/01/16
MLA Appendix 4C - 31 December 2015
29/01/16PRICE SENSITIVE
MLA MLA Finalises Sale of MediVet
22/12/15PRICE SENSITIVE
MLA Release of Restricted Securities from Voluntary Escrow
23/11/15
MLA Medivet Biologics US Animal Health Business
13/11/15PRICE SENSITIVE
MLA Results of Annual General Meeting
13/11/15
MLA Quarterly Report - September 2015
30/10/15
MLA Appendix 4C - 30 September 2015
30/10/15PRICE SENSITIVE
MLA Notice of AGM & Explanatory Memorandum
13/10/15
MLA Appendix 4G
30/09/15
MLA 2015 Annual Report
30/09/15
MLA Revenue Report for Year Ended 30 June 2015
31/08/15
MLA Appendix 4E - 30 June 2015
31/08/15PRICE SENSITIVE
MLA Appendix 3Z - Jeremy Delk
21/08/15
MLA Resignation of Jeremy Delk as a Director
21/08/15
MLA Updated Contact Details for Share Registry
20/08/15
MLA Response to Appendix 4C Query
07/08/15PRICE SENSITIVE
MLA Quarterly Report - 30 June 2015
31/07/15
MLA Appendix 4C - 30 June 2015
31/07/15PRICE SENSITIVE
MLA Change of Share Registry Name
10/07/15
MLA Focus on Human Healthcare & Dilution of Animal Business
23/06/15PRICE SENSITIVE
MLA Appendix 4C - 31 March 2015
30/04/15PRICE SENSITIVE
MLA Quarterly Report - 31 March 2015
30/04/15PRICE SENSITIVE
MLA Notice of Change of Interests of Substantial Holder
20/03/15
MLA Form 603 - Notice of Initial Substantial Holder
20/03/15
MLA Terms of Incentive Share Scheme - CEO
10/03/15
MLA Half Yearly Commentary
27/02/15
MLA Quarterly Report for Period Ended 31 December 2014
27/02/15PRICE SENSITIVE
MLA Quarterly Report & Appendix 4C - 31 December 2014
30/01/15PRICE SENSITIVE
MLA Updated Contact Details for Share Registry
21/01/15
MLA MLA Subsidiary to help Develop Canine Cancer Treatment
19/01/15PRICE SENSITIVE
MLA Terms of Appointment of CEO
04/12/14
MLA Release of Restricted Securities from Voluntary Escrow
04/12/14
MLA Darryl Ellis appointed as CEO of Medical Australia Limited
02/12/14PRICE SENSITIVE
MLA Release of Restricted Securities from Voluntary Escrow
21/11/14
MLA Notice of Initial Substantial Holder - Pie Funds Management
14/11/14
MLA Becoming a substantial holder
14/11/14
MLA Change in substantial holding
13/11/14
MLA Change in substantial holding notices
13/11/14
MLA Notice in Accordance with the Corporations Act 2001
12/11/14
MLA Amended Number of Shares Issued Pursuant to Rights Issue
12/11/14
MLA Further Amended Notification of Under-Subscriptions
12/11/14
MLA Shares Listed Pursuant to Non-Renounceable Rights Issue
10/11/14
MLA Amended Notification of Under-Subscriptions - Rights Issue
10/11/14
MLA Appendix 3Y - Ian Mitchell
07/11/14
MLA Notification of Under-Subscriptions - Rights Issue
07/11/14
MLA Results of Annual General Meeting
06/11/14
MLA Appendix 4C - 30.9.14
28/10/14PRICE SENSITIVE
MLA Quarterly Report - September 2014
28/10/14PRICE SENSITIVE
MLA Non-Renounceable Rights Issue Offer Document
14/10/14PRICE SENSITIVE
MLA Appendix 3B
14/10/14
refresh Created with Sketch. REFRESH
 

Top Stories

Southern Cross Gold zooms in on 9 new high-grade zones above 20g/t at Golden Dyke

Southern Cross Gold Ltd has found 5.5 metres at 25.4 g/t, with drilling highlighting the presence of multiple zones of mineralisation
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
Chimeric clocks $4.17M R&D tax rebate from Canberra Chimeric Therapeutics (ASX:CHM) has confirmed its receipt of a $4.17M tax rebate from Canberra for R&D activities.
Watchdog takes Webjet to court over alleged 'false' flight prices with hidden fees The Australian Competition and Consumer Commission has alleged Webjet (ASX:WJL) misled its customers @ and breached consumer law in the process @ by billing its available airfares as cheap but failing to properly disclose compulsory service and booking fees that then had an impact on final prices...
Pro Medicus signs landmark $330M deal to roll out imaging platform in US hospitals Pro Medicus Ltd is set to roll out a suite of diagnostic imaging products across the health care system run by Trinity Health
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.